We perform goodwill impairment testing annually for a $4 billion publicly traded manufacturer of over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Specifically, we determine the fair value of six reporting units. We also analyze the fair value of certain indefinite-lived assets and test for the recoverability of certain long-lived assets. Company management relies on our work to satisfy financial reporting requirements. We also assist management with various long-term planning and organizational strategies by performing discount rate and pricing multiple sensitivity analyses related to the impact on reporting unit and intangible asset value under different scenarios.